Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
Tumori(2023)
摘要
Our study indicated that ESCC patients with the presence of TLS had better outcomes and an inflamed immune microenvironment. In addition, both TLS-9 and TLS-12 gene signatures could be used as potential biomarkers for the immunotherapy of ESCC patients.
更多查看译文
关键词
ESCC, TLS, prognosis, immunotherapy, TLS gene-related signatures
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要